ASSAY, 酶聯免疫吸附，B19 痘病毒 IGG
PMA 核准號：P220034 · 2026-08-18
廣告
器材摘要
ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG is the device name listed in this FDA 510(k) record. The listed applicant is DiaSorin, Inc.. It received FDA 510(k) clearance on 2026-08-18. The device is classified under product code MYL. It was reviewed by the MI advisory panel.
常見問題
What is the ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG?
ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG is a medical device that received FDA 510(k) clearance on 2026-08-18. The listed applicant is DiaSorin, Inc..
When did ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG receive FDA 510(k) clearance?
The clearance date for ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG can be found in the official FDA records.
Who is the listed applicant for ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG?
The FDA 510(k) record lists DiaSorin, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG?
The FDA product code for ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG is MYL.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告